Stimulation of MAPK cascades by insulin and osmotic shock: Lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes

Diabetes

Volumn 49, Issue 11, 2000, Pages 1783-1793

  Kayali, A G ^a   Austin, D A ^a   Webster, N J G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; GLUCOSE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; SORBITOL; STRESS ACTIVATED PROTEIN KINASE; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; MOUSE; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0033766405     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.11.1783     Document Type: Article

References (60)

1. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human
2. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: The potential for multiplex signalling
3. The search for physiological substrates of MAP and SAP kinases in mammalian cells
4. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
5. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms [published erratum appears in Science 269:17, 1995]
6. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun
7. Identification and characterization of a predominant isoform of human MKK3
8. Characterization of the structure and function of a novel MAP kinase kinase (MKK6)
9. Human mitogen-activated protein kinase kinase 7 (MKKT) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli
10. Induction of cyclooxygenase-2 by the activated MEKK1 → SEK1/MKK4 → p38 mitogen-activated protein kinase pathway
11. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta
12. Does mitogen-activated-protein kinase have a role in insulin action? The cases for and against
13. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin
14. Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathways
15. Insulin signal transduction through protein kinase cascades
16. Jun N-terminal kinase mediates activation of skeletal muscle glycogen synthase by insulin in vivo
17. Conditional, tissue-specific expression of Q205L Galphai2 in vivo mimics insulin activation of c-Jun N-terminal kinase and p38 kinase
18. Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle
19. Insulin differentially regulates SAPKs/JNKs and ERKs in CHO cells overexpressing human insulin receptors
20. An inhibitor of p38 mitogen-activated protein kinase prevents insulin- stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes
21. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
22. Tyrosine kinase-deficient mutant human insulin receptors (Met1153→IIe) overexpressed in transfected rat adipose cells fail to mediate translocation of epitope-tagged GLUT4
23. Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling [published erratum appears in Biochem J 335:711, 1998]
24. Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes
25. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation
26. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes
27. Insulin increases the association of Akt-2 with Glut4-containing vesicles
28. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells
29. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts
30. Activation of protein kinase C (alpha, beta, and zeta) by insulin in 3T3/L1 cells: Transfection studies suggest a role for PKC-zeta in glucose transport
31. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3kinase during insulin stimulation in rat adipocytes: Potential role in glucose transport
32. Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes
33. Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin
34. A role for phospholipase C activity in GLUT4-mediated glucose transport
35. Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes
36. Potential role of Gab1 and PLCγ in osmotic shock-induced glucose uptake (Abstract)
37. Osmotic shock stimulates GLUT4 translocation in 3T3L1 adipocytes by a novel tyrosine kinase pathway
38. Inactivation and dephosphorylation of protein kinase B alpha (PKBalpha) promoted by hyperosmotic stress
39. Osmotic shock inhibits insulin signaling by maintaining Akt/protein kinase B in an inactive dephosphorylated state
40. Signal transducer and activator of transcription-3 serine phosphorylation by insulin is mediated by a Ras/Raf/MEK-dependent pathway
41. ATF-2 contains a phosphorylation-dependent transcriptional activation domain
42. Transcription factor ATF2 regulation by the JNK signal transduction pathway
43. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents
44. Solution structure of the transactivation domain of ATF-2 comprising a zinc finger-like subdomain and a flexible subdomain
45. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase
46. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis
47. Protein synthesis inhibitors activate glucose transport without increasing plasma membrane glucose transporters in 3T3-L1 adipocytes
48. Evidence of two mechanisms for the activation of the glucose transporter GLUT1 by anisomycin: p38(MAP kinase) activation and protein synthesis inhibition in mammalian cells
49. Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I
50. Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells: Involvement of p38 mitogen-activated protein kinase-mediated pathway
51. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibit ors SB 203580 and PD 98059: SB 203580 also inhibits thromboxane synthase
52. Effect of SB 203580 on the activity of c-Raf in vitro and in vivo
53. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580
54. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs)
55. Conversion of SB 203580-insensitive MAP kinase family members to drug- sensitive forms by a single amino-acid substitution
56. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket
57. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase
58. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6): Comparison of the specificities of SAPK3 and SAPK2 (RK/p38)
59. Insulin does not increase p38 MAP kinase activity or phosphorylation in rat skeletal muscle (Abstract)
60. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis